1. Ministry of Health and Welfare, Korea Centers for Disease Control and Prevention. Korea Health Statistics 2015: Korea National Health and Nutrition Examination Survey (KNHANES VI-3) [Internet]. Cheongju: Korea Centers for Disease Control and Prevention;2016. cited 2017 Dec 18. Available from:
https://knhanes.cdc.go.kr/knhanes/sub04/sub04_03.do?classType=7.
3. Grundy SM, Cleeman JI, Merz CN, Brewer HB Jr, Clark LT, Hunninghake DB, Pasternak RC, Smith SC Jr, Stone NJ. National Heart, Lung, and Blood Institute. American College of Cardiology Foundation. American Heart Association. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. Circulation. 2004; 110(2):227–239.
Article
4. Tripathy JP, Thakur JS, Jeet G, Jain S. Prevalence and determinants of comorbid diabetes and hypertension: Evidence from non communicable disease risk factor STEPS survey, India. Diabetes Metab Syndr. 2017; 11:Suppl 1. S459–S465.
Article
5. Stamler J, Daviglus ML, Garside DB, Dyer AR, Greenland P, Neaton JD. Relationship of baseline serum cholesterol levels in 3 large cohorts of younger men to long-term coronary, cardiovascular, and all-cause mortality and to longevity. JAMA. 2000; 284(3):311–318.
Article
6. Guallar E, Jiménez FJ, van't Veer P, Bode P, Riemersma RA, Gómez-Aracena J, Kark JD, Arab L, Kok FJ, Martín-Moreno JM. EURAMIC-Heavy Metals and Myocardial Infraction Study Group. Low toenail chromium concentration and increased risk of nonfatal myocardial infarction. Am J Epidemiol. 2005; 162(2):157–164.
Article
7. Lombardo YB, Chicco AG. Effects of dietary polyunsaturated n-3 fatty acids on dyslipidemia and insulin resistance in rodents and humans. A review. J Nutr Biochem. 2006; 17(1):1–13.
Article
8. Sirtori CR, Galli C, Anderson JW, Arnoldi A. Nutritional and nutraceutical approaches to dyslipidemia and atherosclerosis prevention: focus on dietary proteins. Atherosclerosis. 2009; 203(1):8–17.
Article
9. Lewicki S, Zdanowski R, Krzyzowska M, Lewicka A, Debski B, Niemcewicz M, Goniewicz M. The role of Chromium III in the organism and its possible use in diabetes and obesity treatment. Ann Agric Environ Med. 2014; 21(2):331–335.
10. Anderson RA. Chromium, glucose intolerance and diabetes. J Am Coll Nutr. 1998; 17(6):548–555.
Article
11. Cefalu WT, Hu FB. Role of chromium in human health and in diabetes. Diabetes Care. 2004; 27(11):2741–2751.
Article
12. Stoecker BJ. Chromium absorption, safety, and toxicity. J Trace Elem Exp Med. 1999; 12(2):163–169.
Article
13. Anderson RA, Polansky MM, Bryden NA, Patterson KY, Veillon C, Glinsmann WH. Effects of chromium supplementation on urinary Cr excretion of human subjects and correlation of Cr excretion with selected clinical parameters. J Nutr. 1983; 113(2):276–281.
Article
14. Kozlovsky AS, Moser PB, Reiser S, Anderson RA. Effects of diets high in simple sugars on urinary chromium losses. Metabolism. 1986; 35(6):515–518.
Article
15. Ginsberg HN. Insulin resistance and cardiovascular disease. J Clin Invest. 2000; 106(4):453–458.
Article
16. Suksomboon N, Poolsup N, Yuwanakorn A. Systematic review and meta-analysis of the efficacy and safety of chromium supplementation in diabetes. J Clin Pharm Ther. 2014; 39(3):292–306.
Article
17. Park K, Seo E. Association between toenail mercury and metabolic syndrome is modified by selenium. Nutrients. 2016; 8(7):E424.
Article
18. Park K, Seo E. Toenail mercury and dyslipidemia: interaction with selenium. J Trace Elem Med Biol. 2017; 39:43–49.
Article
19. Jang J, Morris JS, Park K. Toenail selenium levels and prevalence of dyslipidaemia among Korean adults. Br J Nutr. 2017; 118(6):473–480.
Article
20. Willett W. Nutritional epidemiology. 3rd edition. New York (NY): Oxford University Press;2012.
21. World Health Organization Western Pacific Region. International Association for the Study of Obesity. International Obesity Task Force. The Asia-Pacific perspective: redefining obesity and its treatment [Internet]. Sydney: Health Communications Australia Pty Limited;2000. cited 2017 February 27. Available from:
http://iris.wpro.who.int/handle/10665.1/5379.
22. Pate RR, Pratt M, Blair SN, Haskell WL, Macera CA, Bouchard C, Buchner D, Ettinger W, Heath GW, King AC, Kriska A, Leon AS, Marcus BH, Morris J, Paffenbarger RS, Patrick K, Pollock ML, Rippe JM, Sallis J, Wilmore JH. Physical activity and public health. A recommendation from the Centers for Disease Control and Prevention and the American College of Sports Medicine. JAMA. 1995; 273(5):402–407.
Article
23. Cheng TP, Morris JS, Koirtyohann SR, Spate VL, Baskett CK. The analysis of human nails for 24 elements via k0 and cyclic neutron activation analysis. Nucl Instrum Methods Phys Res A. 1994; 353(1-3):457–460.
Article
24. Garland M, Morris JS, Rosner BA, Stampfer MJ, Spate VL, Baskett CJ, Willett WC, Hunter DJ. Toenail trace element levels as biomarkers: reproducibility over a 6-year period. Cancer Epidemiol Biomarkers Prev. 1993; 2(5):493–497.
25. Lee Y, Park K. Reproducibility and validity of a semiquantitative FFQ for trace elements. Br J Nutr. 2016; 116(5):864–873.
Article
26. Smart GA, Sherlock JC. Chromium in foods and the diet. Food Addit Contam. 1985; 2(2):139–147.
Article
27. Kumpulainen JT. Chromium content of foods and diets. Biol Trace Elem Res. 1992; 32(1-3):9–18.
Article
28. Lendinez E, Lorenzo ML, Cabrera C, López MC. Chromium in basic foods of the Spanish diet: seafood, cereals, vegetables, olive oils and dairy products. Sci Total Environ. 2001; 278(1-3):183–189.
Article
29. Bratakos MS, Lazos ES, Bratakos SM. Chromium content of selected Greek foods. Sci Total Environ. 2002; 290(1-3):47–58.
Article
30. Bai J, Xun P, Morris S, Jacobs DR Jr, Liu K, He K. Chromium exposure and incidence of metabolic syndrome among American young adults over a 23-year follow-up: the CARDIA Trace Element Study. Sci Rep. 2015; 5:15606.
Article
31. Rajpathak S, Rimm EB, Li T, Morris JS, Stampfer MJ, Willett WC, Hu FB. Lower toenail chromium in men with diabetes and cardiovascular disease compared with healthy men. Diabetes Care. 2004; 27(9):2211–2216.
Article
32. Garcia E, Cabrera C, Lorenzo ML, Sánchez J, López MC. Daily dietary intake of chromium in southern Spain measured with duplicate diet sampling. Br J Nutr. 2001; 86(3):391–396.
Article
33. Schuhmacher M, Domingo JL, Llobet JM, Corbella J. Chromium, copper, and zinc concentrations in edible vegetables grown in Tarragona Province, Spain. Bull Environ Contam Toxicol. 1993; 50(4):514–521.
Article
34. Zayed A, Lytle CM, Qian JH, Terry N. Chromium accumulation, translocation and chemical speciation in vegetable crops. Planta. 1998; 206(2):293–299.
Article
35. Lima KV, Lima RP, Gonçalves MC, Faintuch J, Morais LC, Asciutti LS, Costa MJ. High frequency of serum chromium deficiency and association of chromium with triglyceride and cholesterol concentrations in patients awaiting bariatric surgery. Obes Surg. 2014; 24(5):771–776.
Article
36. Krzysik M, Grajeta H, Prescha A, Weber R. Effect of cellulose, pectin and chromium(III) on lipid and carbohydrate metabolism in rats. J Trace Elem Med Biol. 2011; 25(2):97–102.
Article
37. He K. Trace elements in nails as biomarkers in clinical research. Eur J Clin Invest. 2011; 41(1):98–102.
Article